We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Predicting Anti-Diabetes Drug Response Using Fat Cell Genetics

News   Jan 11, 2019 | Original story from University of Pennsylvania School of Medicine

 
Predicting Anti-Diabetes Drug Response Using Fat Cell Genetics

Credit: Mitchell Lazar lab, Metabolism in the Perelman School of Medicine at the University of Pennsylvania.

 
 
 

RELATED ARTICLES

Collaboration Fuels Hunt for New “Orphan Disease” Treatments

News

The National Institutes of Health has awarded a Michigan State University researcher a $2.1 million, five-year grant to search vast databases of existing drugs in the hope that some could be adapted to treat orphan diseases.

READ MORE

Harmful Gene Interactions Trigger Rare Form of GI Tumor

News

The "breakdown" of the normal 3D shape of DNA enables harmful interactions to form between genes in a rare type of gastrointestinal stromal tumors.

READ MORE

Developing Pioneering Cell Therapies for Immunotherapy Non-responders

News

New research signposts a novel, less invasive method to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to currently-approved immune-based treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE